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Previous studies in native tissues have produced conflicting data on the localization and metabolic fate of WT and F508
cystic fibrosis transmembrane regulator (CFTR) in the lung. Combining immunocytochemical and biochemical studies
utilizing new high-affinity CFTR mAbs with ion transport assays, we examined both 1) the cell type and region specific
expression of CFTR in normal airways and 2) the metabolic fate of F508 CFTR and associated ERM proteins in the cystic
fibrosis lung. Studies of lungs from a large number of normal subjects revealed that WT CFTR protein localized to the
apical membrane of ciliated cells within the superficial epithelium and gland ducts. In contrast, other cell types in the
superficial, gland acinar, and alveolar epithelia expressed little WT CFTR protein. No F508 CFTR mature protein or
function could be detected in airway specimens freshly excised from a large number of F508 homozygous subjects,
despite an intact ERM complex. In sum, our data demonstrate that WT CFTR is predominantly expressed in ciliated cells,
and F508 CFTR pathogenesis in native tissues, like heterologous cells, reflects loss of normal protein processing.
INTRODUCTION
Cystic fibrosis (CF) is the most common lethal genetic dis-
ease in the Caucasian population, with 1000 mutations
reported in the CFTR gene (www.genet.sickkids.on.ca/cftr).
Functional studies have revealed that CFTR encodes a
cAMP-regulated Cl channel that is expressed in the apical
plasma membrane (PM) of many epithelial tissues (Kartner
et al., 1992). However, 15 years after the identification of the
CFTR gene, the biological events that lead from mutations in
CFTR to the failure of lung defense against inhaled bacteria
that causes CF lung disease remain controversial. In part,
this controversy reflects the relative paucity of information
describing the expression and function of WT CFTR protein
in the normal lung. Thus, a key starting point for investiga-
tions of the role of CFTR in lung defense is to identify which
airway regions and cell types express CFTR.
A thin (20 m) film of liquid covering the airway sur-
faces is responsible for much of the innate defense of the
lung against inhaled noxious and infectious agents princi-
pally. This film of airway surface liquid (ASL) performs this
function by mediating efficient mucus clearance, and recent
studies suggest the volume of ASL is a major determinant of
mucus clearance rates (Boucher, 2003). Both, the superficial
epithelium (the epithelium lining the airway surfaces) and
the submucosal glands regulate ASL volume, and CFTR has
been reported to regulate ion and water flows in both re-
gions (Boucher, 2003). However, the relative contribution of
the superficial epithelium and submucosal glands to ASL
volume homeostasis and thus to CF airway pathogenesis
remains controversial (Verkman et al., 2003). Historically,
submucosal glands, not the superficial epithelia, have been
considered as the main site of CFTR expression in the lungs
(Engelhardt et al., 1992). Submucosal glands are well devel-
oped in human airways and comprise a system of mucous
(mucin-secreting) and serous (fluid-secreting) acinar tubules
and conducting ducts that secrete a mixture of mucins and
liquid into the lumen of large airways (Burkitt et al., 1996).
An important study (Engelhardt et al., 1992) reported that
CFTR expression in human lungs was highest in submucosal
gland acini, suggesting that decreased gland output of fluid
and antimicrobial factors might cause CF lung disease (Jiang
and Engelhardt, 1998). However, compelling physiological
evidence has recently accumulated suggesting that the su-
perficial epithelium controls the volume of liquid on airway
surfaces. In this view, CF pathogenesis results from the
failure of the superficial epithelium to regulate ASL volume
and mucus clearance (Boucher, 2003). A central question has
been whether low/nondetectable levels of CFTR in the su-
perficial epithelium can account for its role in CF disease and
pathogenesis.
Similarly, there is no consensus on which airway cell
types express CFTR in the superficial epithelium. The cili-
ated cell is believed to be involved in transepithelial ion
transport. Some reports suggest that CFTR is expressed in
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ciliated cells within the surface epithelium (Puchelle et al.,
1992), consistent with a role for CFTR in regulating ASL
volume. However, others report CFTR is expressed in air-
way surface goblet cells (Barasch et al., 1991; Jacquot et al.,
1993; Glick et al., 2001), suggesting a regulatory role for
CFTR in mucin secretion rather than fluid transport. The
accurate description of CFTR expression in the lung thus is
important for understanding the function of CFTR in normal
lung physiology and CF pathogenesis.
Other aspects of CF pathogenesis in the lung are also
controversial. For example, the most common cause of CF in
North America is deletion in CFTR of a codon for phenyl-
alanine 508 (F508). Studies in vitro in cellular models ex-
pressing heterologous or endogenous human CFTR have
suggested that the molecular pathogenesis of F508 CFTR is
related to defective intracellular protein processing and traf-
ficking (Cheng et al., 1990) rather than defective Cl channel
function (Li et al., 1993). The maturation and localization of
F508 CFTR protein in native human tissues, however, have
been difficult to assess because of the limited sensitivity and
specificity of CFTR antibodies and disease-related tissue
damage. Early immunofluorescence studies described local-
ization of WT but not F508 CFTR to the apical PM of the
sweat duct (Cohn et al., 1991; Kartner et al., 1992) and airway
submucosal glands (Engelhardt et al., 1992; Puchelle et al.,
1992). Functional studies also failed to detect a cAMP-de-
pendent Cl secretion in native CF airway and intestinal
epithelia (Boucher et al., 1989; Veeze et al., 1991; Mall et al.,
2004). However, the concept that the pathophysiology of
F508 CFTR in native epithelia reflects predominantly de-
fective processing and protein mislocalization has been chal-
lenged. An immunohistochemical study detected CFTR in
the apical PM at similar intensities in airway and intestinal
epithelia from F508 homozygous and normal subjects, sug-
gesting that the maturation defect of F508 CFTR is tissue-
specific (Kalin et al., 1999). Similarly, recent functional stud-
ies concluded that residual CFTR-mediated Cl secretion
was present in rectal and nasal epithelia from a large sub-
group of F508 homozygous CF subjects (Bronsveld et al.,
2000, 2001).
The controversy concerning F508 CFTR trafficking to the
apical PM has focused principally on the intrinsic folding
properties of the mutant protein and its intracellular matu-
ration (Jensen et al., 1995; Benharouga et al., 2002). However,
it has recently been suggested that scaffolding proteins of the
ezrin-radixin-moesin (ERM) family must be correctly local-
ized at the PM for proper CFTR trafficking and function
(Short et al., 1998; Mohler et al., 1999; Huang et al., 2003).
Epithelial inflammation and remodeling have been reported
to alter ERM protein expression (Laoukili et al., 2001), which
could impair localization of F508 protein to the apical PM.
To date, there have been no colocalization studies of CFTR
(WT or F508) and ERM proteins in the human lung to test
this notion.
In this study, we first sought to identify CFTR expression
in normal airway regions and specific cell types within
native epithelia freshly excised from normal individuals.
Thus, we investigated in the normal lung CFTR expression
in 1) the proximal airways that contain both superficial
epithelia and glands; 2) the distal airway regions that con-
tain only superficial epithelia; and 3) the individual cell
types within the superficial epithelia. Next, we characterized
whether functional F508 CFTR reached the PM in airways
resected from F508 homozygous CF subjects with immu-
nocytological and functional approaches and asked whether
ERM proteins maintained their apical localization in the
presence of persistent CF airways inflammation and infec-
tion. This characterization was made possible by the avail-
ability of highly sensitive/specific CFTR mAbs (Gentzsch et
al., 2003; Mall et al., 2004) and an ample collection of normal
and CF airway tissues.
MATERIALS AND METHODS
Subjects
Freshly excised nasal tissues were obtained from eight normal individuals
(age range, 2–56 y) undergoing surgery for plastic reconstruction or sleep
apnea syndromes and from 7 F508 homozygous CF subjects (age range, 1
mo to 32 y) after polypectomy. Freshly excised bronchial, bronchiolar, and
alveolar specimens were obtained from the resected lungs of 15 F508 ho-
mozygous CF subjects (mean age, 26  3 y; range, 9–38 y) undergoing lung
transplant, and excess tissue from 26 healthy lung transplant donors (mean
age, 37  3 y; range, 6–57 y). The study was approved by the Institutional
Review Board for Protection of Human Rights at the University of North
Carolina at Chapel Hill and the University of Freiburg and written informed
consents were given by subjects/parents of underage subjects.
Tissue Specimens
All the tissues were processed within 1 h of surgical excision. For immuno-
fluorescence/LCM and ISH studies, tissues were quickly embedded in OCT
(Sakura Finetek, Torrance, CA) and cryo-preserved at 80°C. For protein
biochemistry studies, freshly excised nasal and bronchial specimens (0.25
cm2 in size) were scraped with a sterile scalpel to collect the superficial
epithelial layer, which was rapidly frozen in liquid nitrogen and stored at
80°C. For Ussing chamber experiments, thin layers of nasal epithelium were
dissected under a stereomicroscope (Mall et al., 2004). After Ussing chamber
studies, tissues were embedded in OCT and cryo-preserved at 80°C.
In Situ Hybridization
Cryosections (8 m thick) were processed as previously described (Kreda et
al., 2001). Tissues were hybridized at 54°C for 18 h with CFTR sense or
antisense riboprobes (1899–2623 bp) doubly labeled with 35S-UTP and 35S-
CTP (107 cpm/ml). Exposing time to photographic emulsion were 30 d for
nasal and bronchial tissues and 60 d for bronchioles and alveoli. A Nikon
Microphot SA microscope (4 lens; Melville, NY) connected to a 3CC-Chilled
Camera (Sony, Tokyo, Japan) was used to capture the images via Adobe
Photoshop (San Jose, CA). A semiquantitative analysis of ISH signal intensity
was performed in large airways using an arbitrary scale from 0 (background
signal) to 4 (highest signal).
Antibodies and Probes
CFTR mAbs were raised using the full-length human CFTR protein purified
from BHK cells (Mall et al., 2004). Rabbit polyclonal antibodies against EBP50
(Mohler et al., 1999), MUC5AC, and InsP3-receptors (Mohler et al., 2004) were
gifts from Dr. S. Milgram (UNC-CH), Dr. J Sheehan (UNC-CH), and Dr. P.
Mohler (Duke University), respectively; the rabbit polyclonal antibody
against AQP5 (Kreda et al., 2001) and the rat monoclonal antibody (mAb)
against tubulin were from Chemicon (Temecula, CA); the mAb against ezrin
(Mohler et al., 1999) was from BD Transduction Laboratories (San Diego, CA);
the mAb against MUC5AC was from NeoMarkers (Fremont, CA); and mAb
against IV-tubulin from Sigma (St. Louis, MO); all secondary antibodies
were from Jackson ImmunoResearch Laboratories (West Grove, PA). Phalloi-
din labeled with AlexaFluor dyes to identify the actin cytoskeleton, and
concanavalin A fluorescently labeled to identify the endoplasmic reticulum
(Mateo et al., 2003) were from Molecular Probes (Eugene, OR).
Immunofluorescence Studies
Thin frozen tissue sections (8 m) were processed as previously described
(Kreda et al., 2001; Mall et al., 2004). Serial tissue sections were incubated at
4°C overnight with CFTR mAbs 528, 769, or a nonimmune mouse IgG (all at
10 g/ml). For immunodetection, sections were incubated with a Texas Red
anti-mouse IgG Fab fragment alone, or plus AlexaFluor488 phalloidin diluted
1:200 and 1:150, respectively. Tissues were mounted in Vectashield containing
DAPI to label nuclei (Vector Laboratories, Burlingame, CA). In some experi-
ments, reducing (sodium borohydride) or oxidizing agents (hydrogen perox-
ide; both from Sigma) were used after the permeabilization step for epitope
retrieval. Serial tissue sections were incubated with antibodies against
MUC5AC to identify goblet cells, IV-tubulin or tubulin to identify ciliated
cells, AQP5 to identify serous cells in gland acini (Kreda et al., 2001), and ezrin
and EBP50 to stain the scaffolding complex associated with CFTR (Short et al.,
1998; Mohler et al., 1999). In some experiments, CFTR mAbs were coincubated
with polyclonal antibodies against AQP5 and EBP50, or a rat mAb against
tubulin, followed by fluorescent anti-mouse IgG Fab fragment and Alex-
aFluor 633 phalloidin plus either fluorescent anti-rabbit IgG, or anti-rat IgG,
diluted 1:200, 1:150, 1:200, and 1:200 respectively.
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LCM and Analysis of Immunofluorescence Data
Immunofluorescence studies were performed on 2–3 different tissue blocks
per patient, and repeated at least three times for each tissue. For each exper-
iment, two different CFTR mAbs were independently assayed and at least one
assayed in duplicate on nonconsecutive sections. The investigators were
blinded as to the identity and genotype of the tissues when scoring sections.
Image acquisition and analysis were performed in a Leica SP2 AOBS confocal
microscope with an Apochromat 40, NA 1.25 Leica lens (Leica Microsys-
tems, Heidelberg, Germany). Scanning of random areas of the superficial and
glandular epithelia in the tissue sections was performed in the xy-axis, using
three or four independent laser sources (364 nm UV, 488 nm Ar, 568 nm Kr,
and 633 nm HeNe lasers) as required. Scanning parameters were set and
utilized as a constant during data acquisition in different experiments. Images
were processed using Leica (color encoding, magnification bar) and Adobe
Photoshop software (RGB conversion, use of “sharpen filter” to increase
contrast of the DIC images, overlay montage of confocal images, and label-
ing). Overlays of color to grayscale DIC images required a postoverlay cor-
rection of the background using “color balance” that did not affect data
significance.
Ussing Chamber Experiments
Nasal epithelia were mounted in modified micro-Ussing chambers (Mall et al.,
2004). The epithelium was bathed with Kreb’s bicarbonate Ringer at 37°C, and
studied under open circuit conditions with transepithelial resistance (Rte) and
voltage (Vte) determined by applying intermittent (1 s) current pulses (I 
0.5 A). The equivalent short circuit current (Isc) was calculated according to
Ohm’s law (Isc  Vte/Rte). After tissues were equilibrated for 60 min, amilo-
ride (10 M, luminal) was added to block electrogenic Na absorption.
cAMP-dependent Cl secretion was measured as the plateau phase 15 min
after addition of forskolin and 3-isobutyl-1-methylxanthine (IBMX; 1 M and
100 M, both surfaces).
Sequential Immunoprecipitation and Immunoblotting
The superficial epithelial layer from nasal and bronchial tissues from normal
and CF subjects was processed as previously described (Mall et al., 2004).
Well-differentiated Human Bronchial Cultures
Cells from four normal and four F508 homozygous specimens were grown
on permeable supports (Transwell-Col filters, 12-mm diameter, 0.4-m pore
size, Corning Costar, Cambridge, MA) as previously described (Kreda et al.,
2000). After 21 d, the cultures developed Rte  300	cm2. CFTR Cl channel
function was measured with an EVOM (STX2 electrode, World Precision
Instruments, Sarasota, FL) in open circuit configuration. Cultures were equil-
ibrated on both surfaces with Kreb’s bicarbonate Ringer at RT for 30 min, and
then amiloride (100 M) was added to the lumen, Rte and Vte recorded as a
baseline (10 min), and the cAMP-induced response was recorded for 15
min after exposure to forskolin (10 M; bilateral); Isc was calculated from Isc
 Vte/Rte.
After functional studies, the human cultures were assayed for CFTR protein
expression. For biochemical analyses, Transwell membranes were transferred
into microcentrifuge tubes containing cold lysis buffer and subjected to West-
ern blot analyses as above. For immunofluorescence and LCM analyses,
cultures were fixed, permeabilized, and stained, and image acquisition and
analysis performed as above. For LCM analyses of isolated cells, immuno-
stained cells were gently scraped off the Transwell membranes, mounted
under a coverslip, and analyzed by LCM xy scanning as before using a Leica
PlanApo 63 NA 1.2 lens.
Statistics
Bioelectric measurements were performed on 2–4 nasal tissues per individual
and 3–4 cultures per individual. Data were averaged to obtain a single value
for each subject and shown as mean  SEM. Student‘s t test and Mann-
Whitney Rank Sum Test were performed as appropriate; p 
 0.05–0.01 was
accepted to indicate statistical significance.
RESULTS
CFTR Expression in Normal Airways
Four regions of the respiratory tract of a large number of
subjects were examined. The nasal mucosa (upper airways
contain superficial epithelium and submucosal glands. The
nasal mucosa is affected in CF and is the region of the human
airways most frequently used for in vivo and ex vivo func-
tional studies. The 3rd–6th generation bronchi represent the
large (and proximal) airway region. Bronchi are character-
ized by superficial epithelium and submucosal glands and
are also severely affected by CF lung disease. Small or distal
airways (bronchioles) contain only superficial epithelium
and are thought to be the initial site of disease in the CF lung
(Davis, 1993). Finally, the distal lung region (respiratory
bronchioles and alveoli) is lined by superficial epithelia,
which in the alveolar region is of a different type than the
airways and is thought not to be primarily affected in CF
(Davis, 1993).
CFTR mRNA Expression
ISH analyses were performed to assess the expression of
CFTR mRNA in normal airway epithelia. Nasal and bron-
chial airways required shorter exposure time (30 d) to the
radiosensitive emulsion compared with bronchioles and dis-
tal lung (60 d), suggesting that the level of CFTR mRNA
expression decreased distally in the human lung (Figure 1, A
and B). In both, nasal (NT) and bronchial (BR) specimens the
superficial epithelium, but not the submucosal gland acini,
exhibited the most consistent and/or intense ISH signal
(Figure 1A). In nasal epithelium, all the subjects (n  4)
exhibited a continuous ISH signal in the surface epithelium
(3.25  0.25 as scored by a semiquantitative index), whereas
two of four subjects exhibited patchy hybridization signals
in submucosal glands (1.25  0.75). In all bronchial speci-
mens (n  5), the superficial epithelium (2.20  0.48) and
ciliated ducts of the glands (2.75  0.49) exhibited a more
continuous and robust hybridization signal than submuco-
sal gland acini (0.70  0.12). More distally, the intensity of
the ISH signal was higher in the superficial epithelium of the
proximal bronchioles than in the terminal bronchioles. In the
alveoli, the signal was low and too diffuse and uneven to
identify pneumocytes type I or II (Figure 1B).
CFTR Immunolocalization
CFTR expression was also investigated by immunolocaliza-
tion and laser confocal microscopy (LCM) techniques with
recently described mAbs against human CFTR (Gentzsch et
Figure 1. CFTR mRNA expression in normal human airways.
Representative results from CFTR ISH analyses of (A) nasal turbi-
nate (NT, n  4) and bronchial (BR, n  5) epithelia and (B) distal
lung (n  3). Bright field (H&E, left) and dark field (center) of a
tissue section labeled with antisense probe, and dark field of a
consecutive tissue section labeled with sense probe (right) are
shown. Tissues were exposed to radiosensitive emulsion for 30 d
(A) and 60 d (B). Both, nasal and bronchial specimens exhibited
stronger and more consistent ISH signal in the surface epithelium
than in submucosal gland acini. Some gland acini (arrows), ciliated
ducts (arrowheads), proximal (P) and terminal (T) bronchioles, and
alveoli (A) are identified; bar, 1 mm.
S. M. Kreda et al.
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al., 2003; Mall et al., 2004). Briefly, these mAbs recognize
human WT and F508 CFTR heterologously expressed in
epithelial MTE18 and BHK cells with high specificity and
with 10–100 times higher sensitivity than previously pub-
lished antibodies (Cohn et al., 1991; Kalin et al., 1999) in
biochemical and immunocytochemical assays (see Figure 2
in Mall et al., 2004). The mAbs used in this study react with
different and nonoverlapping epitopes within the R-domain
(570 and 217, biochemical studies) and NBD2 domain (596,
528, and 729, biochemical and immunocytochemical studies)
of the CFTR molecule.
CFTR Immunolocalization in Superficial Epithelium of
Proximal Airways In nasal and bronchial airways, the su-
perficial epithelium is tall and pseudostratified and is com-
prised mainly of ciliated (fluid-secreting) cells. It also con-
tains variable numbers of intercalated goblet (mucin-
secreting) cells (Burkitt et al., 1996), which typically secrete
MUC5AC mucin (Perez-Vilar et al., 2003). CFTR immuno-
staining/LCM studies revealed a consistent and clear CFTR
signal in the apical PM of surface columnar cells in the
superficial epithelium of nasal and bronchial airways (see
Figures 2A and 3A). Fluorescent phalloidin was used to
identify the cortical actin adjacent to the apical PM and as a
test of epithelial structural integrity. CFTR immunostained
cells were identified as ciliated cells by morphology (see
differential interference contrast [DIC] plane) and by
costaining with tubulin antibodies in LCM analyses (Figure
2A, inset). CFTR staining of the apical PM was observed in
every ciliated cell and was present in all the subjects ana-
lyzed (n  8 and n  26 for nasal and bronchial specimens,
respectively). Intracellular CFTR staining was low in most
ciliated cells (e.g., associated with the endoplasmic reticu-
lum, which was identified using antibodies against InsP3-
receptors and/or concanavalin A, unpublished data). Of
note, many of the bronchial specimens had a few lumenal
cells that were intensely stained by CFTR mAbs (Figure 3A,
inset). These cells appeared to be ciliated and were scattered
throughout the surface epithelium and ciliated ducts.
Figure 2. CFTR localization in nasal epi-
thelium. Representative localization of
CFTR, ERM proteins, and MUC5AC in
freshly excised nasal tissues; normal (NL;
n  8) and F508 homozygous CF (CF; n 
7) by immunofluorescence and LCM. (A)
Confocal images acquired in four channels
with independent laser sources: left, overlay
of DIC and nuclei staining (DAPI, blue);
center, CFTR (mAb 528, red); right, actin
cytoskeleton (fluorescent phalloidin, green).
Inset: costaining of CFTR (red) and cilia (tu-
bulin, blue) in normal nasal tissue. CFTR is
expressed in the apical PM of all ciliated
cells of normal but not CF tissues. (B) Typ-
ical immunolocalization results for left,
EBP50 (green); center, ezrin (red); right,
MUC5AC (purple) in normal and CF tis-
sues; images are presented as overlays of
confocal planes for DIC, DAPI, and anti-
body stainings. Bar, 40 m.
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Importantly, CFTR-specific apical membrane-associated
staining was not observed in other cell types, including
goblet cells identified with MUC5AC antibodies (Figures 2B
and 3B, inset), or basal cells. These results were confirmed
by high resolution LCM analyses of well-differentiated bron-
chial cultures derived from some of the tissue specimens
included in the study. These cultures developed into a
pseudostratified epithelium and clearly revealed that CFTR
was localized exclusively at the apical PM of ciliated cells
but not in goblet cells or any other cell type (see Figure 9C).
The normal bronchial specimens showed variable degrees
of acute inflammation and goblet cell hyperplasia, which is
expected since lung donors were mechanically ventilated
and evaluated by bronchoscopy before lung harvest (Dr. S.
Randell, UNC-CH, personal communication). Of note, in a
few normal subjects, sections exhibiting intense inflamma-
tion and epithelial hyperplasia displayed intermediate
and/or poorly differentiated cells with intracellular CFTR
staining (unpublished data).
CFTR Immunolocalization in Submucosal Glands of Upper/
Proximal Airways Human submucosal glands consist of
acini of serous (fluid-secreting) and mucous (mucin-secret-
ing) cells and conducting ducts lined by an epithelium that
transitions from simple to pseudostratified (similar to the
superficial epithelium) as the ducts progress toward the
airway lumen. It has been widely accepted that CFTR chan-
nel activity is involved in volume homeostasis of gland
secretions and that CFTR protein is predominantly localized
in gland acini (Engelhardt et al., 1992; Jiang and Engelhardt,
1998). Surprisingly, this study revealed that CFTR immuno-
staining signal in the gland acini was not as strong and
consistent as in the superficial epithelium (Figures 4B and
5A). Nasal specimens from only four of eight subjects
showed specific CFTR immunostaining in the submucosal
gland acini. One specimen showed specific CFTR staining in
all the acinar serous cells in a tissue section (Figure 4A),
whereas the other three specimens exhibited only a few
positive serous acini. CFTR staining was localized exclu-
sively in the apical PM of serous cells, as identified by
morphology (DIC and actin staining confocal images) and
by costaining with aquaporin5 (AQP5; Kreda et al., 2001;
Figure 5B). AQP5 is highly expressed in human submucosal
Figure 3. CFTR localization in bronchial ep-
ithelium. Results in freshly excised bronchial
specimens (normal n  26; F508 homozy-
gous CF; n  15) are presented as in Figure 2.
(A) CFTR is expressed in the apical PM of all
ciliated cells of normal but not CF bronchi;
note in normal, a ciliated cell strongly ex-
pressing CFTR, which is also shown magni-
fied in a different focal plane (inset; bar, 20
m). (B) Typical immunolocalization results
for EBP50, ezrin, and MUC5AC displayed as
in Figure 2. Inset: costaining of CFTR (green)
and MUC5AC (purple) in normal bronchial
tissue. Bar, 40 m.
S. M. Kreda et al.
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glands (Kreda et al., 2001), and studies in the AQP5 knockout
mouse indicate that AQP5 deficiency in the apical mem-
brane of the serous glandular epithelium is associated with
decreased transepithelial water permeability (Song and
Verkman, 2001).
In the bronchial specimens, CFTR immunostaining was
not detected in submucosal gland acini of most normal
bronchial tissues (20 of 26 subjects; Figures 4B and 5A). In
contrast, the CFTR staining signal was stronger and consis-
tent in the apical PM of ciliated cells lining the ciliated ducts
localized in close proximity to (CFTR) negative acini in all
the specimens (Figure 4B). Serial sections stained with ezrin
or EBP50 antibodies revealed intense apical staining of both
ciliated ducts and acini of all normal specimens irrespective
of CFTR staining (Figures 4B and 5B), suggesting that the
minimal CFTR signal in gland acini could not be attributed
to poor tissue preservation. Specific, but moderate CFTR
immunostaining was observed only in a few submucosal
serous acini of 6 normal subjects (6 of 26 subjects, Figure 5A).
Identical results were obtained using the two new CFTR
mAbs, CFTR antibodies from other laboratories, and epitope
retrieval techniques. Importantly, AQP5 staining decorated
the apical PM of serous cells in all nasal and bronchial
specimens, despite the absence of a CFTR signal (Figure 5B),
indicating that the PM of serous cells was intact and protein
localization for other channels was not abnormal.
In sum, in nasal and bronchial airways, the pattern of
CFTR immunolocalization signals (Figures 2–5) was consis-
tent with the pattern of CFTR mRNA expression (Figure
1A), suggesting that CFTR was predominantly expressed in
the superficial epithelium rather than in the gland acini.
Moreover, these results indicate unequivocally that CFTR
was localized to the apical PM of ciliated (fluid-secreting)
cells lining the superficial and gland ductal epithelia.
CFTR Immunolocalization in Small Airways Proximal
bronchioles are lined with ciliated and goblet cells organized
in a pseudostratified epithelium. As in proximal airways, the
CFTR immunostaining signal was clear and consistent in the
apical PM of every ciliated cell of the bronchiolar epithelium
(7 normal subjects, Figure 6A). CFTR was not detected in
Clara cells (note, Clara cells were absent in the human
proximal bronchioles as previously reported by Boers et al.
1999), nor in the PM of goblet cells identified with MUC5AC
antibodies (Figure 6B).
CFTR immunostaining of terminal bronchioles and alveoli
was indistinguishable from the IgG control signal in all the
specimens, despite well-preserved cellular structures in-
cluding the PM as demonstrated by actin cytoskeleton stain-
ing (Figure 7A). High levels of autofluorescence emitted in
most of the visible spectrum in distal lung tissues, may have
masked a CFTR-specific signal, as previously suggested (En-
gelhardt et al., 1994). In contrast, staining of EBP50 and ezrin
was very intense in the apical domain of terminal bronchio-
lar epithelial cells (see below, Figure 7B).
F508 CFTR Expression, Maturation, and Function in CF
Airways
We performed immunolocalization studies in CF airways
excised at time of transplantation to investigate the fate of
F508 CFTR in native airways. Because of the potential for
insensitivity of immunolocalization, we supplemented these
studies with biochemical studies of F508 CFTR protein
maturation and bioelectric studies of function in freshly
Figure 4. CFTR localization in nasal and
bronchial submucosal glands. Immunolocal-
ization results in normal submucosal glands
displayed as in Figure 2. (A) Representative
CFTR nasal (NT) immunolocalization results
for 4 of 8 subjects. (B) Representative bron-
chial (BR) immunolocalization results of
CFTR and ezrin in sequential sections for 20
of 26 subjects. Some gland acini (arrows), cil-
iated ducts (arrowheads), and collecting ducts
(*) are indicated. Bar, 40 m.
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excised CF compared with normal tissues. Finally, to control
for nonspecific effects of in situ inflammation on F508
CFTR processing (Dupuit et al., 1995), we repeated key stud-
ies in cell culture.
CFTR Immunolocalization in F508 Homozygous CF
Airway Epithelia
In proximal airways, nasal (7 subjects) and bronchial (15
subjects) CF specimens exhibited epithelial structures and
preservation comparable to normal tissues (nasal tissues, 8
subjects; bronchial tissues, 26 subjects) as examined by H&E
and actin cytoskeletal staining and confocal DIC planes (Fig-
ures 2A and 3A). In contrast to the consistent and clear CFTR
immunostaining signal in the apical PM of surface ciliated
cells observed in all normal subjects, we failed to detect
specific CFTR immunostaining in any cell type in the CF
nasal and bronchial superficial epithelia of any CF subjects
(Figures 2A and 3A).
In CF bronchial tissues, morphological differences associ-
ated with chronic infection were present in most of the CF
specimens, e.g., goblet cell hyperplasia, consistent with
lungs from CF subjects undergoing lung transplantation.
Accordingly, in most cases, more than one bronchial speci-
men from each of the 15 F508 homozygous CF patients was
analyzed for CFTR immunolocalization and bronchial areas
with clearly identifiable epithelial morphology (e.g., pres-
ence of ciliated cells) were utilized in the study. Epithelial
areas presenting advanced metaplasia and/or tissue dam-
age were not included in the comparative analyses between
both groups. In most CF bronchial specimens, metaplasic
tissues showed an absence of CFTR expression in the apical
PM of superficial cells, but in a few CF subjects, intracellular
Figure 5. CFTR expression in bronchial sub-
mucosal gland acini. (A) CFTR immunolocal-
ization results in bronchial submucosal gland
acini displayed as in Figure 2; top panel, neg-
ative CFTR staining in normal acini (n  20/
26); middle panel, positive CFTR staining in
normal acini (n  6/26); bottom panel, ab-
sence of staining in CF acini (n  15). (B)
Typical immunolocalization results displayed
as in Figure 2 for ezrin, AQP5 (green), and
MUC5AC. The lumen of some serous glands
is indicated by arrows. Bar, 40 m.
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CFTR staining was observed in some intermediate and/or
nondifferentiated cells (unpublished data). Staining for
MUC5AC revealed that the number and distribution of gob-
let cells varied according to the degree of inflammation in
CF specimens. CF nasal tissues displayed moderate signs of
epithelial inflammation and goblet cell hyperplasia (Figure
2B), whereas bronchial tissues showed extensive goblet cell
hyperplasia (Figure 3B). Interestingly, MUC5AC staining
was also observed in the “mucus plaques” lining the surface
of many bronchial CF specimens (Figure 3B).
Submucosal glands in all CF subjects also displayed an
absence of specific CFTR immunostaining signal in any
gland cell type (Figure 5A) despite intense staining for AQP5
in the apical domain of acinar serous cells (Figures 5B).
Speculation has been raised about AQP5 role in submucosal
gland secretory functions and whether AQP5 expression
could be altered in CF (Verkman et al., 2003). In this study,
the intensity of AQP5 staining in serous cells was not dif-
ferent in CF versus normal tissues, suggesting that the ex-
pression levels of AQP5 protein are not altered in CF. Inter-
estingly, although not detected in normal glands, MUC5AC
immunostaining was observed in scattered gland mucous
cells of CF submucosal glands (Figure 5B).
In the CF proximal (Figure 6A) and terminal bronchioles
and alveoli (Figure 7A, insets), no specific CFTR staining
was detected in any epithelial cell type (9 subjects) despite
well-preserved epithelial cell integrity as demonstrated by
actin cytoskeleton staining and DIC images (Figures 6A and
7A). MUC5AC staining indicated the presence of goblet cells
in proximal bronchioles and was again observed in the
“mucus plaques” lining the surface of CF proximal bronchi-
oles (Figure 6B).
In sum, CFTR immunolocalization studies indicate that
F508 homozygous CF subjects exhibited undetectable lev-
els of CFTR protein in the apical PM of epithelial cells
throughout all the airway regions.
cAMP-dependent Cl Secretion in F508 Homozygous CF
Nasal Tissues
CFTR Cl channel activity was examined in freshly isolated
nasal tissues that were also subjected to CFTR protein local-
ization (see above) and maturation studies (see below). Both
Figure 6. CFTR localization in proximal
bronchiolar epithelium. Representative im-
munolocalization results in normal (n  7)
and F508 homozygous CF (n  9) bronchi-
oles displayed as in Figure 2 for (A) CFTR and
(B) EBP50, ezrin, and MUC5AC. Bar, 40 m.
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indices of Na transport, i.e., basal and amiloride-sensitive
equivalent short circuit current (Isc), were significantly in-
creased in nasal epithelia from five F508 homozygous CF
subjects compared with seven normal specimens. Impor-
tantly, after blockade of Na transport, forskolin/IBMX in-
duced a significant Cl secretory response in normal (31.0 
8.1 A.cm2) but not F508 homozygous CF nasal tissues
(0.5  0.8 A.cm2; Figure 8, A and B). These data indicate
that CFTR-mediated Cl secretion is absent in F508 ho-
mozygous CF nasal epithelia.
Biochemical Analyses of Freshly Excised CF versus
Normal Epithelia
Nasal and bronchial tissues utilized in immunolocalization
(and functional) studies were also subjected to Western blot
analysis to investigate CFTR protein maturation. CFTR is a
glycoprotein that separates into two well-defined bands in a
denaturing gel. The slower band is the fully glycosylated
mature protein or band “C” (180–190 kDa), which corre-
sponds to the CFTR protein localized in the PM and mem-
brane compartments in transit to the PM. The faster band or
band “B” (160 kDa) corresponds to the core-glycosylated
immature protein that has not progressed beyond the endo-
plasmic reticulum. Both mature (band C) and immature
(band B) CFTR protein bands were observed in tissues from
normal individuals (nasal, 3 subjects; bronchial, 10 subjects).
In contrast, CF tissues from F508 homozygous CF individ-
uals (nasal, 3 subjects; bronchial, 10 subjects) exhibited only
band B, i.e., the immature protein form of CFTR (Figure 8, C
and D). These results indicate that CF tissues express unde-
tectable levels of mature protein in epithelial cells.
Interestingly, both normal and CF tissues exhibited only a
low level of core-glycosylated CFTR protein (Figure 8, C and
D), which corresponded to the absence of specific intracel-
lular immunostaining of ciliated cells in normal and CF
airways (Figure 3A). In contrast, heterologous overexpres-
sion systems often display a higher level of core-glycosy-
lated CFTR protein and intracellular immunostaining in
cells expressing either WT or F508 CFTR (Mall et al., 2004).
This phenomenon probably reflects either higher protein
Figure 7. CFTR localization in terminal
bronchioles and alveoli. Representative im-
munolocalization results in terminal bronchi-
oles (TB) and alveoli (AL) of normal lungs for
(A) CFTR and (B) EBP50 and ezrin. Insets:
immunolocalization results in F508 ho-
mozygous CF lungs. Bar, 40 m.
S. M. Kreda et al.
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synthetic rates in heterologous cells or that core-glycosy-
lated CFTR protein may be processed more efficiently into
mature protein and/or disappear faster in native tissues.
Bronchial Epithelial Cultures
CFTR expression/function studies were performed in well-
differentiated bronchial cultures derived from some speci-
mens included in the immunolocalization study. Immuno-
fluorescence and high-resolution LCM studies of normal
cultures revealed that CFTR was expressed at the apical PM
of columnar cells in this pseudostratified epithelium (Figure
9A). CFTR localization was identified exclusively in the
apical PM of ciliated cells but not in goblet cells or any other
cell type (Figures 9, B and C). Similar studies revealed that
CF cultures also exhibited a pseudostratified epithelium, but
CFTR was not detected in the apical PM of any cell type
(Figures 9, A and B). Normal cultures exhibited mature
CFTR protein (180–190 kDa) by Western blot, whereas
F508 homozygous cultures exhibited only immature CFTR
protein (160 kDa; Figure 9D).
CFTR Cl channel activity was measured in bronchial
cultures as forskolin (cAMP)-dependent Cl secretion after
amiloride pretreatment. In normal cultures, forskolin in-
duced a large secretory current (Isc  26.1  2.9 A/cm2,
range 14.2–38.1 A/cm2, 4 subjects). In contrast, forskolin
failed to induce Cl secretion in any CF culture (Isc  1.9 
0.5 A/cm2, range 0.3 to 4.0 A/cm2, 4 subjects, p 

0.01; Figure 9E).
In sum, F508 homozygous CF bronchial cultures pro-
duced identical results to those in native bronchial tissue.
There were undetectable levels of mature CFTR protein in
the apical PM of epithelial culture cells, and CFTR-mediated
Cl secretion was absent in F508 homozygous CF airway
cultures.
Expression of ERM Proteins in Native Airway Epithelia
from Normal and F508 Homozygous CF Individuals
We focused on EBP50 and ezrin localization as these are the
most widely studied ERM proteins relevant to positioning
CFTR within the PM (Short et al., 1998; Mohler et al., 1999).
Nasal, Bronchial, and Bronchiolar Superficial Epithelia
The distribution and intensity of EBP50 and ezrin immuno-
fluorescence was indistinguishable in normal and CF spec-
imens from nasal (Figure 2B), bronchial (Figure 3B), and
proximal bronchiolar (Figure 6B) regions. Both proteins co-
localized to the apical region of columnar cells, overlapping
mostly with the cortical actin staining signal and to a high
contrast line observed in the DIC plane characteristic of
microvilli. The highest intensity of EBP50 and ezrin staining
was in the microvilli of ciliated cells.
Airway Submucosal Glands
Ezrin and EBP50 antibodies produced intense apical staining
in ciliated and collecting ducts and in acini of the submuco-
sal glands in all normal and CF nasal and bronchial speci-
mens (Figures 4B and 5B).
Terminal Bronchioles and Alveoli
EBP50 and ezrin colocalized to the apical PM of all epithelial
cuboidal cells of the terminal bronchioles and alveolar epi-
thelial cells in both normal and CF specimens (Figure 7B). In
both, normal and CF specimens the intensity of the staining
signals were similar in all airway regions for ezrin but
appeared to be decreased in the alveoli for EBP50.
DISCUSSION
There has been little agreement about the localization of
CFTR in native airway epithelia. (Engelhardt et al., 1992,
1194; Puchelle et al., 1992; Kalin et al., 1999; Penque et al.,
2000). With the availability of very sensitive anti-CFTR
mAbs (Mall et al., 2004) and LCM technologies, we initiated
a comprehensive study to explore two major issues contro-
versial in CF research: 1) the cell type specific localization of
CFTR in the normal lung; and 2) the localization of F508
CFTR in native airway epithelium. With respect to this latter
issue, we also sought to test whether absence of F508 CFTR
in the apical PM reflected an abnormal metabolic fate of
F508 CFTR within the cell or abnormalities in the scaffold-
ing protein complex that associates with CFTR in the PM
that may be disrupted by the chronic inflammation associated
with CF. A summary of the data are presented in Table 1.
Normal Airway Superficial Epithelia
CFTR mRNA expression was detected throughout the sur-
face epithelium of nasal, tracheal (unpublished data), bron-
chial, and proximal bronchiolar tissues from normal indi-
viduals. The level of the mRNA expression appeared to
decrease distally through the airways, consistent with pre-
vious PCR data (Trapnell et al., 1991) and functional studies
(Knowles et al., 1981).
CFTR protein, as detected by immunolocalization, was
first reported in a few unidentified columnar cells within the
superficial epithelium (Engelhardt et al., 1992, 1994) and
Figure 8. CFTR function and protein expression in nasal and bron-
chial epithelia from normal and F508 homozygous subjects. CFTR
Cl channel activity in response to forskolin/IBMX was examined
in freshly excised nasal tissues from normal (n  6) and CF (n  5)
subjects in modified Ussing chambers. (A) Representative transep-
ithelial voltage (Vte ; mV) traces for normal and CF tissues. (B)
cAMP induced short circuit current (Isc; A/cm2) data for each
group, mean  SEM, p 
 0.05. (C) Representative immunoblot of
tissues studied in A. (D) Representative immunoprecipitation/im-
munoblot of freshly excised bronchial tissues studied in Figure 3
(normal, n  10; CF, n  10). Position of mol wt markers in KDa,
CFTR mature (band C, arrowhead) and core-glycosylated (band B,
arrow) proteins are indicated.
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more recently in a restricted population of columnar cells
(Penque et al., 2000; Carvalho-Oliveira et al., 2004). We iden-
tified the ciliated cell as the only cell type expressing CFTR
in nasal, bronchial, and proximal bronchiolar surface epithe-
lia by high resolution LCM and coimmunostaining with
antibodies against cellular markers (e.g., tubulin). CFTR pro-
tein was expressed at the apical PM of all ciliated cells in a
continuous pattern along the airway surfaces, consistent
with its mRNA distribution.
Interestingly, we found a few ciliated cells scattered along
the surface epithelium of bronchi and proximal bronchioles
with very high levels of CFTR protein expression (Figure 3A,
inset). These “hot cells” may correspond to the small popu-
lation of cells immunostained by CFTR antibodies with less
sensitivity (Engelhardt et al., 1992) than ours.
In terminal and respiratory bronchioles and alveoli, there
is absence of specific CFTR immunostaining signal, which
mirrors the low level of expression suggested by ISH as
previously reported (Engelhardt et al., 1994). Because there
are no early pathological changes in distal lung associated
with CF, we speculate that the low levels of CFTR expres-
sion reflect a less important role for CFTR than other Cl
channels in fluid homeostasis in this pulmonary region.
Function of Normal Superficial epithelia in Mucus/Fluid
Balance
Ciliated but not goblet (mucin-secreting) cells are predicted
to be involved in airway epithelial ion and water transport
(Cotton et al., 1987). This study clearly demonstrated that
CFTR protein is expressed in all ciliated cells within the
Figure 9. CFTR protein expression and func-
tion in normal versus F508 homozygous bron-
chial epithelial cultures. Well-differentiated cul-
tures (normal, n  4; CF, n  4) were subjected
to protein expression and Cl transport func-
tion analyses. (A) LCM xz images of CFTR (red)
and actin cytoskeleton (green) localization on
normal and CF cultures; arrow denotes a non-
ciliated cell; bar, 20 m. (B) LCM xy images for
stained cells isolated from normal (CFTR,
green; cilia, red) and CF (CFTR, green) cultures
(note the cortical actin cap in the goblet cell
pointed by the arrow). (C) LCM xy images for
costained CFTR (green) and either MUC5AC
(red) or tubulin (red) cells isolated from normal
cultures. Ciliated (arrowheads) and goblet (ar-
rows) cells are indicated; bar, 8 m. CFTR is
expressed in the apical PM of normal but not
CF ciliated cells, nor in goblet cells of either
group. (D) Representative immunoblot of nor-
mal and CF cultures; labels as in Figure 8. (E)
CFTR Cl transport function in normal and CF
cultures; Isc data presented as mean  SEM
(p 
 0.01) in response to forskolin/IBMX.
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surface epithelium and is consistent with a significant role
for CFTR in airway fluid balance. Other studies, however,
have reported CFTR expression in mucous cells by immu-
nohistochemistry (Jacquot et al., 1993; Kalin et al., 1999) and
CFTR regulation of mucin sialylation and sulfation and
granule exocytosis (Barasch et al., 1991; Glick et al., 2001).
However, consistent with our data that CFTR is not ex-
pressed in goblet cells, mucin granule secretion rates have
been reported not to differ in CF versus normal epithelium
(Lethem et al., 1993), and there is little evidence for abnormal
modifications of mucins in CF in the absence of infection/
inflammation (Roussel, 2001). Thus, we conclude that CFTR
does not directly regulate mucin composition or expression,
but rather CFTR exhibits a dual function as mediator of Cl
secretion and regulator of ENaC-mediated Na transport
that maintains ASL volume homeostasis.
Submucosal Glands of Normal Airways
A previous study (Engelhardt et al., 1992), indicating that
gland acinar serous cells were the predominant site for
CFTR expression in the human large airways, argued for a
dominant role of submucosal glands in ASL volume regu-
lation and CF pathogenesis (Jiang and Engelhardt, 1998).
Surprisingly, we found little or no CFTR in gland acinar cells
by immunofluorescence/LCM analyses. In our study, only
4/8 normal nasal turbinates showed apical immunostaining
of serous gland acinar cells, whereas only 6/26 bronchial
tissues showed some level of apical immunostaining in se-
rous gland acinar cells (Figures 4 and 5). Consistent with the
immunolocalization data, our ISH studies indicated that
CFTR mRNA expression is routine in the surface epithelium
and ciliated ducts but scattered in the gland acini of large
airways (Figure 1A). The explanation as why there is a
difference in the pattern of CFTR expression in the submu-
cosal glands among normal subjects remains obscure, and
further investigation is required to understand the implica-
tion of this finding. However, it is noteworthy that a previ-
ous report also described that CFTR immunostaining signal
within the submucosal gland acini was variable, i.e., only in
2 of 4 normal subjects (Kalin et al., 1999).
Function of Glands in Airway Fluid Balance
Our data showing minimal, variable expression of CFTR in
serous acinar cells suggest a more minor role for CFTR in
airway gland acinar fluid secretion (volume production).
Thus, these observations conflict with previous reports sug-
gesting CFTR is the predominant mediator of gland acinar
secretion, based on high CFTR immunolocalization signals
in acinar serous cells (Engelhardt et al., 1992), studies of
agonist regulation of porcine and human gland secretion
rates (Joo et al., 2002; Ballard and Inglis, 2004), and studies of
CalU-3 cells, which have been used as a model system of
acinar serous cells (Shen et al., 1994).
Our observations also appear to conflict with ex vivo
studies of CF gland preparations that have shown decreased
agonist-stimulated glandular secretion rates and a more vis-
cous (increased mucin concentration) secretion, implying
that CFTR is involved in regulating glandular fluid volume
(Jayaraman et al., 2001; Joo et al., 2002). However, in every
functional ex vivo study of normal and CF tissues, all the
glandular components (e.g., acini and ducts) and adjacent
gland tissue/cells (e.g., muscle cells) were exposed to the
pharmacological stimulus, and glandular secretions were
analyzed at the duct entrance onto the airway surface (Joo et
al., 2002; Verkman et al., 2003; Ballard and Inglis, 2004).
Therefore, only the final secretion product was analyzed. In
this context, we found CFTR expressed in all ciliated cells of
ciliated ducts, and in scattered cells of the collecting ducts
(unpublished data). Therefore, these data support a role of
CFTR regulating glandular secretion homeostasis, but indi-
cate that this CFTR function predominates in the submuco-
sal ducts rather than the serous acini.
Expression of F508 CFTR in CF Airway Epithelia
Immunofluorescence and LCM analyses of nasal (n  7),
bronchial (n  15), and bronchiolar and alveolar (n  9) CF
specimens revealed a complete absence of CFTR immuno-
staining signal in the apical PM of ciliated cells or any other
cell type in these epithelia. The absence of staining could not
be attributed to poor reactivity of the mAbs against F508
CFTR (Mall et al., 2004) or to tissue damage because stain-
ings of actin cytoskeleton, ezrin, and EBP50 were robust in
the CF tissues and not different from normal specimens.
Consistent with the immunolocalization data, biochemical
analyses of excised superficial mucosa from the nasal and
bronchial CF tissues indicated that F508 CFTR protein did
not progress beyond the endoplasmic reticulum, as sug-
gested by the absence of mature CFTR protein and the
presence of only the immature, core-glycosylated CFTR pro-
tein B band (Figure 8).
A functional assessment of CFTR channel activity is likely
more sensitive than protein immunodetection. Therefore,
we assayed for Cl channel function in F508 CF and nor-
mal freshly excised nasal tissues. Normal nasal tissues dis-
played a large CFTR-mediated Cl secretion. In contrast,
there was a complete absence of cAMP-dependent–medi-
ated Cl secretion in F508 homozygous subjects (n  5;
Figure 8). Comparable data were obtained in cultured nor-
Table 1. Summary of the data for the analyses of protein expression






Prox. bronchiolar 7/7 0/9
Term. bronchiolar ND/7 ND/9
Nasal subm. gland
Acinus 4/8 -
Ciliated duct 8/8 -
Bronchial subm. gland
Acinus 6/26 0/15
Ciliated duct 26/26 0/15
Bronchial cultures 4/4 0/4
CFTR protein maturationb
Nasal tissue 3/3 0/3
Bronchial tissue 10/10 0/10
Bronchial culture 4/4 0/4
CFTR Channel functionc
Nasal tissue 7/7 0/5
Bronchial culture 4/4 0/4
Data are expressed as a fraction of the number of positive subjects
vs. the total number of subjects examined. ND, nondetectable spe-
cific signal above background fluorescence emission.
a Expression of CFTR protein at the apical PM of ciliated cells
(surface epithelium and ciliated ducts) and serous cells (submucosal
glands) identified by immunofluorescence/LCM analysis
b Presence of mature protein identified by Western blot.
c CFTR Cl channel activity determined as cAMP-dependent short
circuit current in the presence of amiloride.
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mal and CF airway epithelia (Figure 9). Thus, we conclude
there is no functional or biochemical evidence for F508
CFTR reaching the apical PM of human airway epithelium
in vivo.
There are several possible reasons why our data and
conclusions differ from some previous reports. First, our
mAbs exhibit very high affinity for CFTR and hence may be
less cross-reactive with other apical PM proteins in the CF
lung compared with CFTR antibodies (Claass et al., 2000)
used in previous studies (Kalin et al., 1999; Penque et al.,
2000; Carvalho-Oliveira et al., 2004). Second, we applied
multiple, complementary techniques to the same specimens.
Finally, the ability to culture epithelial cells from aliquots of
the same freshly excised specimens used for localization and
protein studies provided an alternative strategy to minimize
the effects of inflammation on CFTR expression (Dupuit et
al., 1995).
Expression of Scaffolding Proteins Ezrin and EBP50 in
Airway Epithelia
We localized ezrin and EBP50 to the apical PM of human
airway epithelial cells (Short et al., 1998; Mohler et al., 1999;
Ingraffea et al., 2002; Kulaksiz et al., 2002). Both proteins
colocalized to the microvillus domain of epithelial cells in
nasal, tracheal, bronchial, and bronchiolar superficial epithe-
lia and were expressed at equivalent levels in CF and normal
epithelia. Ezrin and EBP50 staining were readily detected in
the apical PM of all ciliated cells but nondetectable in goblet
cell apical membranes. In gland regions, ezrin and EBP50
were found to be coexpressed at high levels in the apical PM
of cells in the collecting and acinar-serous ducts. Ezrin was
also sometimes observed expressed alone in basolateral PMs
of columnar cells, in PMs of basal cells, and in the apical PM
of alveolar cells. These findings are in agreement with pre-
vious reports indicating that some epithelial cells express
one but not both proteins (Ingraffea et al., 2002).
In sum, there were no evident changes in the pattern of
expression of these ERM proteins in CF tissues, suggesting
that ERM protein localization was not affected by Pseudomo-
nas infection and inflammation (in disagreement with
Laoukili et al., 2001; Maresso et al., 2004), or a defect in F508
CFTR trafficking. Importantly, failure of F508 CFTR to
localize in the apical PM of CF cells could not be attributed
to faulty ERM protein expression.
CONCLUSIONS
There is an evolving consensus that CF pathogenesis reflects
ASL volume depletion. To explain this deficiency, one hy-
pothesis has focused on the superficial epithelium as initi-
ating and maintaining the ASL volume deficit (Boucher,
2003), whereas another hypothesis has focused on defective
gland acinar secretory function (Verkman et al., 2003). Our
data demonstrate that the predominant site of CFTR expres-
sion is the superficial epithelium of all airway regions in-
cluding bronchiolar epithelium that is the site of early dis-
ease, suggesting a key role for the superficial epithelium in
the initiation of ASL volume depletion. Defective gland
secretion may well exacerbate ASL volume depletion, but
our data suggest that this deficit may reflect defective CFTR
expression/function in gland ductal rather than acinar epi-
thelial cells. Therefore, therapeutic approaches might prof-
itably focus on reestablishing CFTR function in the superfi-
cial epithelium.
In this context, speculation has been raised in the gene
therapy literature as to which cell types and what fraction of
cells in the superficial epithelium of the CF airway must be
transduced with WT CFTR to restore normal ion-liquid
transport (Johnson et al., 1992). Our data demonstrate that
normal airway epithelia express CFTR in every ciliated cell
and hence suggest that a goal for CF gene therapy is to
transduce WT CFTR in all ciliated cells. In contrast, it may
not be necessary to transduce submucosal gland serous cells.
Two competing hypotheses describe the metabolic fate of
F508 CFTR in affected epithelium in vivo. One maintains
that F508 CFTR protein reaches the PM in airway and
intestinal epithelial cells in a tissue-specific manner to pro-
duce some Cl channel function in CF subjects (Kalin et al.,
1999; Bronsveld et al., 2000). The alternative hypothesis
maintains that regardless of the tissue, F508 CFTR protein
does not fully mature and escape the endoplasmic reticulum
quality control mechanisms, and hence, reach the PM to
express Cl channel activity (Mall et al., 2004). If the first
hypothesis is correct, effective therapeutic agents should
address mainly deficient channel activity of F508 CFTR. If
the second hypothesis is correct, enhancement of maturation
and apical PM localization of F508 CFTR is the therapeutic
goal. The data presented here support the second hypothe-
sis.
Finally, much speculation exists whether proteins that
associate with CFTR in functional multiprotein complexes
are deficient in the CF epithelia. This study demonstrates
that two relevant scaffolding proteins are expressed and
correctly localized in all airway regions of the CF lung, at
levels similar to those observed in normal airway epithelia.
Therefore, therapeutic approaches that attempt to reestab-
lish CFTR function in airway epithelial cells appear plausible.
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